embecta Embarks on New Journey: Making Diabetes Care More Effective and More Manageable

Diabetes diagnoses rise globally year after year. The International Diabetes Foundation (IDF) reports that 537 million adults are currently living with diabetes. That number will increase sharply over the next 25 years, according to embecta (EMBC) Chief Executive Officer Dev Kurdikar, by almost 250 million. In a recent interview, Kurdikar discussed just how prevalent diabetes is globally and how embecta is accelerating the journey to better diabetes management.

Although 537 million is an astounding number to grasp, to give some perspective, in the United States, over one in 10 people, or 11.3%, of the U.S. population is living with the disease today. According to the Centers for Disease Control and Prevention, it is the 7th leading cause of death in the U.S.

As part of its mission to increase public awareness and encourage health improvement for those living with diabetes, the IDF called for increase[d] access to diabetes education to help improve the lives of the more than half a billion people living with diabetes worldwide. This call is where embecta comes in; as a medical device company that recently split off from leading global medical technology company BD, its sole mission to make diabetes management and education more efficient, accessible and effective.